Health Outcomes, Discrimination, and Stigma Among Sexual and Gender Minority People With Inflammatory Bowel Disease
- PMID: 40197744
- PMCID: PMC12455600
- DOI: 10.1093/ibd/izaf054
Health Outcomes, Discrimination, and Stigma Among Sexual and Gender Minority People With Inflammatory Bowel Disease
Abstract
Background: Sexual and gender minority (SGM) individuals often experience more discrimination and worse health than non-SGM people. Less is known about SGM individuals with inflammatory bowel disease (IBD). We studied IBD outcomes, discrimination, illness-related stigma, and SGM status in a cross-sectional survey.
Methods: In total, 1586 IBD Partners e-cohort participants self-reported sexual orientation, gender identity, and prior IBD treatment. They completed the Short Crohn's Disease Activity Index or Simple Clinical Colitis Activity Index, the Everyday Discrimination Scale, and the Paradox of Self Stigma (PASS-24) scale. We performed regression analyses controlling for age, race, disease duration, and IBD type.
Results: SGM people were 7.8% (n = 124) of the cohort. SGM participants were younger than non-SGM participants (median age 40 vs. 54 years, P < .001). Among SGM individuals, 67% (n = 74) were in remission based on disease activity scores. Among non-SGM individuals, 74% (n = 936) were in remission (P = .097). Similar proportions of SGM and non-SGM persons reported prior IBD-related hospitalization (40% vs. 37%, P = .426; adjusted odds ratio [aOR] 0.95, 95% confidence interval [CI], 0.62-1.45) and IBD-related surgery (52% vs. 54%, P = .707, aOR 1.25, 95% CI, 0.81-1.94). SGM respondents reported more discrimination (71% vs. 47%, P < .001), and 43% of SGM individuals reported healthcare-related discrimination versus 21% of non-SGM individuals (P < .001). SGM persons also endorsed more internalized stigma (median PASS-24 scores 53 vs. 47, P = .026).
Conclusions: SGM individuals with IBD are more likely to experience discrimination, including in healthcare, and illness-related stigma. These may significantly impact the quality of life and should be considered in the care of SGM people with IBD.
Keywords: Crohn’s disease; LGBTQ; health disparities; patient-reported outcomes; ulcerative colitis.
Plain language summary
In a national survey, we found that sexual and gender minority (SGM) individuals with inflammatory bowel disease are more likely to experience discrimination, including in healthcare, and illness-related stigma than non-SGM individuals.
© The Author(s) 2025. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
K.L.N.: grant funding for registry development from Pfizer. PDRH: Consultant for AbbVie, Buhlmann Labs, Celltrion, Curacle, Eli Lilly; advisor for GI Health Foundation. M.D.L.: Consulting for Takeda, Pfizer, Janssen, AbbVie, BMS, Lilly, Intercept, Target RWE, Prometheus, Research support: Takeda, Pfizer, Lilly. P.A.W.: none.
Comment in
-
Inclusive Inflammatory Bowel Disease Care for Sexual and Gender Minorities: An Urgent Need in Uncertain Times.Inflamm Bowel Dis. 2025 May 12;31(5):1483-1486. doi: 10.1093/ibd/izaf059. Inflamm Bowel Dis. 2025. PMID: 40237308
References
-
- Jones JM. U.S. LGBT identification steady at 7.2%. Gallup. 2023. Accessed March 12, 2025. https://news.gallup.com/poll/470708/lgbt-identification-steady.aspx
-
- Fish JN, Turpin RE, Williams ND, Boekeloo BO. Sexual identity differences in access to and satisfaction with health care: findings from nationally representative data. Am J Epidemiol. 2021;190(7):1281-1293. doi: https://doi.org/ 10.1093/aje/kwab012 - DOI - PMC - PubMed
-
- Flentje A, Heck NC, Brennan JM, Meyer IH. The relationship between minority stress and biological outcomes: a systematic review. J Behav Med. 2020;43(5):673-694. doi: https://doi.org/ 10.1007/s10865-019-00120-6 - DOI - PMC - PubMed
-
- Newman KL, Velez C, Paul S, Radix AE, Streed CG, Targownik LE. Research considerations in digestive and liver disease in transgender and gender-diverse populations. Clin Gastroenterol Hepatol. 2023;21(10):2443-2449.e2. doi: https://doi.org/ 10.1016/j.cgh.2023.06.008 - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
